Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R, Kitazono S, Yanagitani N, Horiike A, Ichinose J, Matsuura Y, Nakao M, Mun M, Nishio M, Okumura S, Motoi N, Ito T, Miyazaki Y, Inase N, Ishikawa Y. Sakakibara R, et al. Am J Surg Pathol. 2020 Jun;44(6):757-764. doi: 10.1097/PAS.0000000000001444. Am J Surg Pathol. 2020. PMID: 32118626
MuLBSTA score is a useful tool for predicting COVID-19 disease behavior.
Iijima Y, Okamoto T, Shirai T, Mitsumura T, Sakakibara R, Honda T, Ishizuka M, Tateishi T, Tamaoka M, Aiboshi J, Otomo Y, Anzai T, Takahashi K, Miyazaki Y. Iijima Y, et al. Among authors: sakakibara r. J Infect Chemother. 2021 Feb;27(2):284-290. doi: 10.1016/j.jiac.2020.10.013. Epub 2020 Oct 13. J Infect Chemother. 2021. PMID: 33129694 Free PMC article.
Predictors associated with clinical improvement of SARS-CoV-2 pneumonia.
Mitsumura T, Okamoto T, Shirai T, Iijima Y, Sakakibara R, Honda T, Ishizuka M, Aiboshi J, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Mitsumura T, et al. Among authors: sakakibara r. J Infect Chemother. 2021 Jun;27(6):857-863. doi: 10.1016/j.jiac.2021.02.012. Epub 2021 Feb 16. J Infect Chemother. 2021. PMID: 33676842 Free PMC article.
Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.
Tasaka Y, Honda T, Nishiyama N, Tsutsui T, Saito H, Watabe H, Shimaya K, Mochizuki A, Tsuyuki S, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Kobayashi M, Chiaki T, Yamashita T, Tsukada Y, Taki R, Jin Y, Sakashita H, Natsume I, Saitou K, Miyashita Y, Miyazaki Y. Tasaka Y, et al. Among authors: sakakibara r. Lung Cancer. 2021 May;155:120-126. doi: 10.1016/j.lungcan.2021.03.014. Epub 2021 Mar 22. Lung Cancer. 2021. PMID: 33798901
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases.
Mitsumura T, Kumaki Y, Takahashi K, Matsudera S, Sakakibara R, Honda T, Ishizuka M, Iijima Y, Shirai T, Okamoto T, Tateishi T, Sakashita H, Miyake S, Ikeda S, Miyazaki Y. Mitsumura T, et al. Among authors: sakakibara r. Thorac Cancer. 2021 Sep;12(18):2508-2512. doi: 10.1111/1759-7714.14098. Epub 2021 Aug 10. Thorac Cancer. 2021. PMID: 34378333 Free PMC article.
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. Sakashita H, et al. Among authors: sakakibara r. Thorac Cancer. 2022 May;13(9):1267-1275. doi: 10.1111/1759-7714.14376. Epub 2022 Mar 23. Thorac Cancer. 2022. PMID: 35322551 Free PMC article. Clinical Trial.
Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe Cases.
Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Mitsumura T, et al. Among authors: sakakibara r. Jpn J Infect Dis. 2022 Sep 22;75(5):504-510. doi: 10.7883/yoken.JJID.2022.080. Epub 2022 May 31. Jpn J Infect Dis. 2022. PMID: 35650037 Free article.
COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease.
Tateishi T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Mitsumura T, Shibata S, Honda T, Shirai T, Okamoto T, Tamaoka M, Sasai T, Miyazaki Y. Tateishi T, et al. Among authors: sakakibara r. Intern Med. 2023 May 1;62(9):1323-1328. doi: 10.2169/internalmedicine.8877-21. Epub 2023 Feb 8. Intern Med. 2023. PMID: 36754401 Free PMC article.
512 results